LDHAL6A
Basic information
Region (hg38): 11:18455824-18479601
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LDHAL6A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 0 | 0 |
Variants in LDHAL6A
This is a list of pathogenic ClinVar variants found in the LDHAL6A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-18456706-T-C | not specified | Uncertain significance (Aug 15, 2023) | ||
11-18456763-C-A | not specified | Uncertain significance (Mar 31, 2023) | ||
11-18465640-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
11-18465661-A-G | not specified | Uncertain significance (Sep 25, 2023) | ||
11-18465700-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
11-18475523-T-C | not specified | Uncertain significance (Feb 17, 2024) | ||
11-18475600-T-G | not specified | Uncertain significance (May 30, 2022) | ||
11-18475604-A-G | not specified | Uncertain significance (Aug 11, 2022) | ||
11-18475637-G-C | not specified | Uncertain significance (Feb 06, 2024) | ||
11-18475638-T-G | not specified | Uncertain significance (Jan 30, 2024) | ||
11-18476410-G-A | not specified | Uncertain significance (Aug 26, 2022) | ||
11-18476444-T-A | not specified | Uncertain significance (Dec 16, 2023) | ||
11-18477715-G-C | not specified | Uncertain significance (Dec 28, 2022) | ||
11-18478707-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
11-18478718-A-G | not specified | Uncertain significance (Jan 22, 2024) | ||
11-18478778-C-T | not specified | Uncertain significance (May 11, 2022) | ||
11-18478794-T-G | not specified | Uncertain significance (Mar 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LDHAL6A | protein_coding | protein_coding | ENST00000280706 | 7 | 23777 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.78e-10 | 0.0524 | 125480 | 0 | 259 | 125739 | 0.00103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.272 | 170 | 180 | 0.943 | 0.00000900 | 2193 |
Missense in Polyphen | 56 | 63.027 | 0.8885 | 885 | ||
Synonymous | -0.991 | 72 | 62.1 | 1.16 | 0.00000307 | 634 |
Loss of Function | -0.217 | 14 | 13.2 | 1.06 | 6.36e-7 | 168 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00167 | 0.00167 |
Ashkenazi Jewish | 0.000603 | 0.000595 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000926 | 0.0000924 |
European (Non-Finnish) | 0.00161 | 0.00160 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000534 | 0.000523 |
Other | 0.000497 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Displays an lactate dehydrogenase activity. Significantly increases the transcriptional activity of JUN, when overexpressed. {ECO:0000269|PubMed:18351441}.;
- Pathway
- Pyruvate metabolism - Homo sapiens (human);Glycolysis / Gluconeogenesis - Homo sapiens (human);Propanoate metabolism - Homo sapiens (human);Cysteine and methionine metabolism - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Beta-mercaptolactate-cysteine disulfiduria;Warburg Effect;Pyruvate Dehydrogenase Complex Deficiency;Primary hyperoxaluria II, PH2;Pyruvate kinase deficiency;Gluconeogenesis;Leigh Syndrome;Glycogenosis, Type IA. Von gierke disease;Glycogenosis, Type IC;Cysteine Metabolism;Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease;Pyruvate Metabolism;Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency);Triosephosphate isomerase;Fructose-1,6-diphosphatase deficiency;Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1);Cystinosis, ocular nonnephropathic;Glycogenosis, Type IB;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;lactate fermentation (reoxidation of cytosolic NADH);The citric acid (TCA) cycle and respiratory electron transport;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.483
Intolerance Scores
- loftool
- 0.423
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.32
Haploinsufficiency Scores
- pHI
- 0.0854
- hipred
- N
- hipred_score
- 0.242
- ghis
- 0.411
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.796
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- carbohydrate metabolic process;carboxylic acid metabolic process;oxidation-reduction process
- Cellular component
- cytoplasm;extracellular exosome
- Molecular function
- L-lactate dehydrogenase activity